Effects of methimazole in the early and established phases of N(G)-nitro-L-arginine methyl ester hypertension

European Journal of Endocrinology

Volumn 135, Issue 4, 1996, Pages 506-513

  Vargas, Félix ^a   Fernandez Rivas, Antonio ^a   Osuna, Antonio ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Servicio de Nefrologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; THIAMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; HYPOTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

EID: 0029994216     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350506     Document Type: Article

References (28)

1. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-8
2. Sabio JM, Fernández-Rivas A, Vargas F. Role of nitric oxide in the hypotensive response to acetylcholine in conscious rats. Med Sci Res 1993;21:795-7
3. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992;20:298-303
4. Fernández-Rivas A, García-Estañ J, Vargas F. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J Hypertens 1995;13:123-8
5. Chappel CI, Rona G, Reversz C, Cahill J. Effect of propylthiouracil on adrenal-regeneration hypertension in the rat. Proc Soc Exp Biol Med 1958;98:23-6
6. Salgado E. Effect of thyroidectomy on hypertension, nephrosclerosis and cardiac lesions produced by deoxycorticosterone acetate (DCA) treatment in the rat. Endocrinology 1954;55:112-5
7. Fregly MJ. Effects of propylthiouracil on development and maintenance of renal hypertension in rats. Am J Physiol 1958;194:149-54
8. Rioux F, Berkowitz BM. Role of the thyroid gland in the development and maintenance of spontaneous hypertension in rats. Circ Res 1977;40:306-12
9. Rodger RL, McNeill JH. Antihypertensive effect of thyroidectomy in SHR: associated changes in heart performance. Am J Physiol 1986;250:600-5
10. Rials SJ, Sullivan MM, Hansen JR. Effects of thyroidectomy on blood pressure of DOCA-hypertensive rats. Fed Proc 1982;41:1660
11. Vargas F, Garcia del Rio C, Luna JD, Haro JM, Osorio C. Studies on thyroid activity in deoxycorticosterone-salt and Goldblatt two-kidney, one-clip hypertensive rats. Acta Endocrinol (Copenh) 1988;118:22-30
12. Andrade J, Haro JM, Jódar E, Luna JD, Vargas F. Effects of methimazole on low renal mass hypertension: changes on blood pressure and pressor responsiveness to vasoconstrictors. Pharmacology 1992;44:315-23
13. Andrade JL, Haro JM, Sabio J, García del Rio C, Vargas F. Effects on renal function and digoxin-like immunorreactivity produced by methimazole in low-renal mass hypertension. Clin Exp Hypertens A 1992;14:1003-16
14. Vargas F, Atucha N, Sabio JM, Quesada T, García-Estañ J. Pressure-diuresis-natriuresis response in hyper- and hypothyroid rats. Clin Sci 1994;87:323-8
15. Scheffe H. The analysis of variance. New York: Wiley, 1959
16. Snedecor GW, Cochran WG. Statistical methods. Iowa: The Iowa State University Press, 1980
17. Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990;15:486-92
18. Vargas F, Baz MJ, Andrade J, Luna JD, Haro JM. Thyroid state and pressor responsiveness to vasoconstrictors in conscious rats. Med Sci Res 1991;19:239-41
19. Sabio JM, Rodriguez-Maresca M, Luna JD, García del Río C, Vargas F. Vascular reactivity to vasoconstrictors in aorta and renal vasculature from hyperthyroid and hypothyroid rats. Pharmacology 1994;49:257-64
20. Vargas F, Castillo MA, Haro JM. Methimazole treatment reduces cardiac hypertrophy and mortality without a concomitant reduction in blood pressure in established Goldblatt two-kidney one clip hypertension. Experientia 1992;48:755-8
21. Folkow B. Structural factor in primary and secondary hypertension. Hypertension 1990;16:89-101
22. Brown JJ, Davies DL, Morion JJ, Robertson JI, Cuesta V, Lever AF. Mechanism of renal hypertension. Lancet 1976;1:1219-21
23. Arnal JF, El Amrani AI, Chatellier G, Ménard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993;22:580-7
24. Jover B, Herizi A, Ventre F, Dupont M, Miniran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993;21:944-8
25. Arnal JF, Warin L, Michel JB. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992;90:647-52
26. Bradley SE, Stéphan F, Coelho JB, Reville P. The thyroid and the kidney. Kidney Int 1974;6:346-65
27. Epstein FH. Estimating the effect of preventing obesity on total mortality and hypertension. Int J Obes 1979;3:163-6
28. Vargas F, Baz MJ, Luna JD, Andrade J, Jódar E, Haro JM. Urinary excretion of digoxin-like immunoreactive factor and arginine-vasopressin in hyper- and hypothyroid rats. Clin Sci 1991;81: 471-6